EMA adds formulation, closure flexibility to biosimilar guidance
The EMA has joined the FDA in proposing to accept different biosimilar formulations and closures in revised draft guidelines.
Archives for June 4, 2012
Round up of CMO M&A
Outsourcing-Pharma presents a roundup of M&A activity in the CMO space, including Piramal on the hunt for deals and Siegfried buying AMP.